Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Dovato 50/300
Active Ingredients:	Dolutegravir sodium 52.6mg equivalent to dolutegravir 50mg Lamivudine 300mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	Glaxo Wellcome SA, Burgos, Spain GlaxoSmithKline LLC, North Carolina, United States of America

*Product:*	Oncaspar
Active Ingredient:	Pegaspargase 3750U
Dosage Form:	Powder for injection
New Zealand Sponsor:	Servier Laboratories NZ Ltd
Manufacturer:	Lyophilization Services of New England Inc, New Hampshire, United States of America

Dated this 8th day of December 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule